Tamer MA Ewieda

doi:10.19080/JAICM.2019.09.555770

Research Article

Nitroglycerin as Adjuvant to Two Different Doses of Lidocaine During IVRA for Hand Surgery

Tamer MA Ewieda*

Department of Anesthesia, Al-Azhar University, Egypt

Submission: August 31, 2019; Published: October 18, 2019

*Corresponding author: Tamer MA Ewieda, Department of Anesthesia, Faculty of Medicine, Al-Azhar University, Egypt

How to cite this article: Tamer MA Ewieda. Nitroglycerin as Adjuvant to Two Different Doses of Lidocaine During IVRA for Hand Surgery. J Anest & Inten Care Med. 2019; 9(4): 555770. DOI: 10.19080/JAICM.2019.09.555770

Abstract

Objectives: To evaluate anesthetic and operative outcome of using nitroglycerin (NTG) as an adjunct to intravenous regional anesthesia (IVRA).

Patients and methods: 165 patients assigned for elective hand and forearm surgery were divided into three equal groups: Control group received lidocaine 2% (3mg/kg) and Study groups received NTG 200μg with full (Group I) or half-dose LA (Group II) diluted with saline for total volume of 40ml. Tourniquet was deflated at 30min in study groups, irrespective of surgery duration and at end of surgery in control group. Study outcomes include onset and recovery times of sensory and motor blocks, need for intraoperative (IO) and postoperative (PO) analgesia, PO pain scores and duration till hospital discharge.

Results: NTG favorably improved anesthetic procedure with significantly shorter onset-time of blocks and longer onset-time of tourniquet pain. NTG/half-dose LA combination also did favorably than LA alone, but less than NTG/full-dose LA. Duration till block full recovery was significantly longer in NTG patients than controls with lower pain scores and analgesia consumption. Duration of PO analgesia was non-significantly longer in group II than control group but was significantly different in favor of group I than other groups. Twenty-seven patients received no PO analgesia with significant difference in favor of NTG than control groups. No patient developed drug-related complications or hemodynamic alterations. Duration of hospital stay was significantly shorter in NTG patients than controls.

Conclusion: Use of IVRA for hand and distal forearm surgery is efficient and safe modality for IO anesthesia and PO analgesia. Addition of NTG to LA improved anesthetic outcome and allowed shortening of initiation of surgery, less IO and PO analgesic consumption. Reduction of LA dose did not compromise the reported improved anesthetic outcome. Rapid tourniquet release did not alter patients hemodynamic.

Abstract: IVRA; Nitroglycerin; Tourniquet release; Rescue analgesia; Outcome

Introduction

Most surgeries at the wrist and forearm are performed using a tourniquet to minimize blood loss [1] and are carried upon under general anesthesia [2], local infiltration [3], brachial plexus blocks [2] or intravenous regional anesthesia (IVRA) [4]. IVRA is an effective method of providing anesthesia for extremity surgery, with published success rates ranging from 94% to 98% [5]. Despite of the settled efficacy of IVRA, it may be associated with serious complications related to local anesthetic (LA) toxicity that may be occurred secondary to LA leak [6], accidental tourniquet release or rapid tourniquet deflation [7]. However, exsanguinations of the limb prior to tourniquet inflation decrease the amount of blood distal to the cuff and this reduces blood in the surgical field and may limit peak plasma levels of LA when the cuff is deflated [8]. Nitroglycerin (NTG) has a rapid onset of action and short half-life with a clear dose-response curve on both global hemodynamics and peripheral circulation [9]. Nitrates predominantly induce vasodilation in large capacitance blood vessels and impair platelet aggregation [10]. Nitric oxide (NO) is a biological mediator that blocks the nociceptive stimulus in the peripheral nervous system through an increase in postsynaptic neuron GMPc [11]. NTG is metabolized in the cell giving rise to short lived intermediates, which liberate NO that activates the guanylate cyclase enzyme, increasing the GMPc [12]. Time of tourniquet application was determined according to patients’ tolerance to ischemic pain [13] and tourniquet must be released gradually or using intermittent episodes of inflation and deflation to allow gradual wash of LA so as to minimize the possible LA-related side effects [14].

Hypothesis

This study hypothesized that NTG as an adjunct to IVRA, owing to its vasodilator effect allow rapid and perfect tissue perfusion of LA, thus may improve performance of IVRA and allow tourniquet release without time limit, thus improving anesthetic outcome and may allow reduction of LA dose without compromising the outcome.

Setting

Doha Clinic Hospital, Qatar

Design

Prospective study

Patients and Methods

The study was conducted at Department of Anesthesia at Doha Clinic Hospital, Qatar since Nov 2016 till Nov 2017. The study protocol was approved by the Local Ethical Committee and only patients who signed written fully informed consents were enrolled in the study. All ASA I and II patients who were assigned for elective hand, wrist or distal forearm surgery requiring operative time range of 45-90min were included in the study. Patients needed urgent or emergency surgery, had extensive hand trauma, cardiac, renal or hepatic diseases, past history of habitual hypotension or allergy to study drugs or intolerant to tourniquet pain were excluded from the study. All patients underwent clinical examination to assure inclusion and exclusion criteria and to determine baseline demographic and clinical data. All patents were premedicated with 0.1mg/kg midazolam and atropine 0.01mg/kg; administered intramuscularly 45 minutes prior to surgery, for sedation and relief of apprehension; but no analgesics or opiates were given. Two intravenous cannulas were applied, one in the operative extremity for administration of the study solution and the other in the contra-lateral extremity for intravenous injection of other medications or fluids when indicated. After application of routine monitors, a double pneumatic tourniquet was positioned on the upper arm of the operative extremity that was exsanguinated from distal to proximal by elevation for 2min followed by application of Esmarch bandage to induce circulatory isolation of arm that was confirmed by inspection of the color of the limb, absence of radial pulse and loss of pulse oximetry tracing. Then, the proximal tourniquet was inflated up to 100mmHg above baseline systolic blood pressure, but not exceeding 250mmHg, and Esmarch bandage was removed [15].

Patients were randomly, using sealed envelopes prepared by blinded assistant and chosen by patients themselves, divided into three equal groups: Control group included patients received preservative free lidocaine 2% in a dose of 3mg/kg and calculated amount was diluted with saline up to a total volume of 40ml without additives. Study group I targets to evaluate the additive effect of NTG and included patients received preservative free lidocaine 2% in a dose of 3mg/kg and calculated amount was mixed with 200μg of nitroglycerin and was diluted with saline up to a total volume of 40ml. Study group II targets to outcome of IVRA using 200μg of nitroglycerin and half-dose of LA used for other groups (lidocaine 2% in a dose of 1.5mg/kg) diluted with saline up to a total volume of 40ml. Anesthetic solutions were prepared by an assistant who was blinded about study hypothesis and patients’ randomization. Solution which was assigned for each group was injected intravenously through the cannula applied in the operative extremity through 90 seconds. On sensation of discomfort at the proximal tourniquet site, it was deflated after inflation of the distal tourniquet to the same pressure. In all groups, the tourniquet was not kept inflated for >2h, but was deflated at 30min in study groups, irrespective of duration of surgery, while in control group the tourniquet was deflated on completion of surgery. For all patients two-stage tourniquet deflation was followed where tourniquet was deflated for 10 seconds and re-inflated for 1 minute before the final release so as to allow for a more gradual “washout” of local anesthetic [16].

Intraoperative assessment

a) Cutaneous sensation was checked using pin prick method every minute all over the front and dorsum of the hand and forearm and time elapsed since drug injection till sensory block was achieved in all dermatomes was determined as duration till onset of sensory block.

b) Motor block was defined as loss of ability to flex and extend fingers and wrist; time till achieving motor block since drug injection was determined as duration till onset of motor block.

c) Intraoperative analgesia was evaluated by Visual Analogue Scale (VAS) of 0-10 every 10 minutes (0=“no pain” and 10=“worst pain imaginable”). Time of onset of tourniquet pain was defined as time lapsed between complete sensory block till patient feels pain scored at >3 on the VAS scale. Intravenous fentanyl injection was given in a dose 1μg/kg to patients who had tourniquet pain of >3. The numbers and total dose of IO fentanyl injections was also recorded.

d) Mean arterial pressure (MAP) and heart rate (HR) were non-invasively monitored throughout duration of surgery.

e) Operative time and time till release of tourniquet were also recorded.

Postoperative assessment

a) Durations till complete sensory recovery and motor recovery were defined as the time elapsed from release of tourniquet to full sensory recovery and return of full motor activity, respectively.

b) Duration of PO analgesia was defined as time till first analgesic request of rescue analgesia. Rescue analgesia was given on VAS>4 in the form of intramuscular injection of diclofenac sodium (75mg/ml; 3ml ampoule).

c) MAP, HR and VAS pain score were recorded hourly for 4 hours.

d) Frequency of LA or NTG-related complications, as sensitivity reactions, altered hemodynamic parameters was recorded.

e) All patients were managed as one-day surgical case and duration since complete sensory and motor recovery till hospital-discharge was recorded as time of PO hospital stay.

Statistical analysis

Sample size was calculated using the standard nomogram proposed by Kraemer & Thiemann [17] and a sample size of ≥40 patients per group was determined to be sufficient to detect a difference at the 5% significance level and give the trial 80% power [18]. Sample size and power were re-calculated and assured using Power and Sample Size Calculation Software program provided by Department of Biostatistics, Vanderbilt University. Obtained data were presented as mean±SD, ranges, numbers and ratios. Results were analyzed using Student t-test, ANOVA test and Chi-square test (X2 test). Statistical analysis was conducted using the IBM SPSS (Version 23, 2015) for Windows statistical package. P value <0.05 was considered statistically significant.

Results

Data are presented as mean±SD and numbers; percentages are in parenthesis.

One hundred and seventy-eight patients were eligible for evaluation, 13 patients were excluded, and 165 patients were included (Figure 1). There was non-significant (p<0.05) difference between patients of the study groups as regards inclusion data as shown in (Table 1). Mixing LA solution with NTG favorably improved the anesthetic procedure where duration till onset of sensory and motor blocks were significantly shorter with significantly longer time till onset of tourniquet pain that required fentanyl injection in patients of study groups than patients of control group (Table 2). Also, combination of NTG and half-dose LA did favorably in comparison to LA alone but showed significantly longer duration till onset of sensory block and significantly shorter time till onset of tourniquet pain compared to patients received NTG and full-dose LA (Table 2). However, the difference between patients of study groups I and II as regards onset of motor block and the total consumed dose of fentanyl was nonsignificant, despite being in favor of full dose. All surgeries were conducted uneventfully with no hemodynamic alterations and duration of surgery showed non-significant difference between the three groups (Table 2). Duration till sensory and motor full recovery was significantly longer in all patients received NTG than patients received LA alone with significantly longer durations in patients of study group I than those of study group II (Table 3). At 1-hr PO, mean PO pain VAS scores were significantly lower in patient of study groups compared to control patients with significant difference between both study groups in favor of study group I (Table 3). Thereafter, the inter-group difference was nonsignificant. Duration of PO analgesia was significantly longer in patient of study group II compared to patients of other groups with non-significantly longer duration of PO analgesia documented by patients of study group II compared to control patients (Table 3). At time of discharge, 27 patients were discharged without requesting rescue analgesia; 13 and 10 in study groups I and II, and only four in control group with significantly higher frequency of patients requested rescue analgesia in control versus patients of study groups I (p=0.018) and II (p=0.0482), while the difference was non-significant (p=0.086) between patients of study groups I and II, but in favor of group II (Table 3). No patient developed LA or NTG-related complications or hemodynamic alterations. All patients were managed as one-day case, but patients of study groups were discharged after significantly shorter duration than control patients with significant difference between patients of study groups in favor of study group I (Table 3).

Data are presented as mean±SD and numbers; percentages are in parenthesis;

P1 indicates significance of difference versus control group;

P2 indicates significance of difference versus Study I group;

*: indicates significant difference

Data are presented as mean±SD and numbers; percentages are in parenthesis;

P1 indicates significance of difference versus control group;

P2 indicates significance of difference versus Study I group;

*: indicates significant difference

Discussion

Nitroglycerin (NTG) as an adjuvant to local anesthetic (LA) during IVRA for elective hand and distal forearm surgeries favorably and significantly improved anesthetic outcome; using either lidocaine 3 or 1.5mg/Kg in 40ml saline, manifested as significantly shorter block initiation time, longer block duration, lower tourniquet pain scores and IO fentanyl consumption. Additionally, NTG/LA combination allowed better PO course manifested as significantly lower scores at 1-hr PO and nonsignificantly lower scores till end thereafter and lower number of requests of rescue analgesia thus significantly shortened time of PO hospital stay. The obtained results go in hand with Asadi & Mehri [19] and Cakmak et al. [20] who in similar comparative studies, found the onset time of sensory and motor blockades was shorter and mean recovery time of sensory blockade was longer with significantly lower opioid consumption in patients received NTG/LA combination versus LA only. Thereafter, Bansal et al. [21] compared the efficacy of magnesium sulphate and NTG as adjuncts during IVRA and reported shorter sensory and motor block onset times and significantly prolonged recovery times with both drugs compared to lidocaine alone and concluded that addition of either of magnesium sulphate and NTG to lidocaine for IVRA lead to early onset of sensory block and prolonged PO analgesia. The significantly shorter onset and delayed block recovery in patients received NTG/LA versus patients received LA alone could be attributed to a direct potent vasodilatory effect that promotes rapid in situ diffusion of LA to nerves, or to direct stimulation of peripheral nerve fibers by an action similar to that of locally applied acetylcholine, or to inherent anti-nociceptive effect of NTG. In support of the anti-nociceptive effect of NTG, the reported lower IO and PO pain VAS scores and the lesser consumption of rescue analgesia by patients who received half-dose of LA compared to patients received LA only. Moreover, the current study provided an evidence for dose dependent NTG analgesic effect. Such antinociceptive effect of NTG could be attributed to the facts that NTG is metabolized in the cell to nitric oxide [22], which increases the intracellular concentration of cyclic guanosine monophosphate, a pain modulator acting both centrally and peripherally [23] through sensitization of wide-dynamic-range neurons located in the superficial and deep dorsal horns and through attenuation of inhibition of these neurons caused by stimulated periaqueductal gray secondary to transmission of painful stimuli [24]. As another possible explanation for the favorable outcome of IVRA using NTG/LA, is the synergistic interaction between μ-opioid receptors and NO [25] where NO has direct modulatory effects on N-methyl- D-aspartate receptors [26] and gamma-aminobutyric acid-A receptors [27].

The release of tourniquet at 30min IO, irrespective of operative duration in patients of study groups passed smoothly without significant hemodynamic effects secondary to the use of LA with/without NTG. These findings indicated the safety of IVRA using LA alone or in combination with NTG. In support of the safety of NTG, Honarmand et al. [28] compared the effect and safety of IVRA using NTG/LA combination in three doses; 200, 300 and 400μg and detected superior effect of IVRA using NTG/ LA combination versus LA alone and no deleterious hemodynamic effects even with the high NTG dose which is double of the dose used in the present study. Thereafter, Asadi & Mehri [19] detected no difference between patients received NTG/LA combination or LA alone in hemodynamic parameters before tourniquet inflation, at any time after inflation and after its deflation.

Conclusion

The use of IVRA for hand and distal forearm surgery is efficient and safe modality for IO anesthesia and PO analgesia. Addition of NTG to LA improved anesthetic outcome and allowed shortening of initiation of surgery, less IO and PO analgesic consumption. Reduction of LA dose did not compromise the reported improved anesthetic outcome. Rapid tourniquet release did not alter patients hemodynamic.

JAICM.MS.ID.555770

Our Media Partner

JAICM Menu

Useful Links

Downloads